10177-10-3

Basic information

• Product Name: 2-CHLORO-5-PHENYLNICOTINONITRILE
• Synonyms: 2-CHLORO-5-PHENYLNICOTINONITRILE
• CAS NO: 10177-10-3
• Molecular Formula: C₁₂H₇ClN₂
• Molecular Weight: 214.65
• Mol File: 10177-10-3.mol
• Article Data: 4

Chemical Properties

• Melting Point: 143-147°C
• Boiling Point: 376.2 °C at 760 mmHg
• Flash Point: 181.3 °C
• Appearance: /
• Density: 1.3 g/cm³
• Vapor Pressure: 7.36E-06mmHg at 25°C
• Refractive Index: 1.632
• CAS DataBase Reference: 2-CHLORO-5-PHENYLNICOTINONITRILE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-CHLORO-5-PHENYLNICOTINONITRILE(10177-10-3)
• EPA Substance Registry System: 2-CHLORO-5-PHENYLNICOTINONITRILE(10177-10-3)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 10177-10-3(Hazardous Substances Data)

Usage

General Description

2-Chloro-5-Phenyl nicotinonitrile is a chemical compound with a molecular formula of C13H8ClN3. The chemical falls under the classification as a nicotinonitrile derivative and is characterized by a ring structure in its molecular composition. These types of chemicals are commonly used in the agricultural sector as pesticides and in the pharmaceutical industry. As with many chemical compounds, 2-Chloro-5-Phenyl nicotinonitrile requires careful handling and specific storage conditions to preserve its integrity and prevent potential hazards. The physical and toxicological properties of this compound are yet to be fully documented and would require further research for comprehensive understanding.

InChI:InChI=1/C12H7ClN2/c13-12-10(7-14)6-11(8-15-12)9-4-2-1-3-5-9/h1-6,8H

Upstream product

• 35982-93-5 1,2-dihydro-2-oxo-5-phenyl-3-pyridinecarbonitrile 
• 405224-23-9 5-bromo-2-chloropyridine-3-carbonitrile 
• 98-80-6 phenylboronic acid 
• 176433-57-1 2-chloro-5-phenyl-3-pyridine carboxaldehyde 
• 10026-13-8 phosphorus pentachloride 

Downstream Products

• 1100051-11-3 5-phenyl-2-phenylethynyl-pyridine-3-carbonitrile 
• 85128-54-7 3-cyano-2-mercapto-5-phenylpyridine 
• 1355015-46-1 C₂₃H₁₇NO₃ 
• 1355015-47-2 C₂₃H₁₅NO₂ 
• 1355015-45-0 C₂₃H₁₆N₂O 
• 881297-95-6 2-(morpholin-4-yl)-5-phenylpyridine-3-carbonitrile 
• 1415354-73-2 2-(benzylamino)-5-phenylpyridine-3-carbonitrile 
• 1415354-66-3 1-benzyl-6-phenyl-1H-pyrido[2,3-d]pyrimidin-4-one 
• 1415354-74-3 2-(methylamino)-5-phenylpyridine-3-carbonitrile 
• 1415354-75-4 2-(butylamino)-5-phenylpyridine-3-carbonitrile 
• 1268121-64-7 2-(dimethylamino)-5-phenylpyridine-3-carbonitrile 
• 405224-21-7 5-phenyl-1H-pyrazolo[3,4-b]pyridin-3-amine 

Relevant articles and documents

Cyano-azobenzene compound and application thereof and Contains organic electroluminescent device of this compound

and Contains the organic electroluminescent device of the compound, and the cyanazine compound has the structure of the formula (1), wherein X. 1 -X5 Each is independently represented C or N. Moreover X. 1 -X5 There 1 - 3 were chosen to N. Cyano groups only at X1 -X5 The substitution is performed at the time of a carbon atom, and the cyano group is at X. 1 -X5 The number is 1 - 3 integer. , The sum ≤ 5 of the number of nitrogen atoms and cyano groups. The formula (2) represents Ar structures. The compound is used as a host material, an electron transport material, a hole blocking material or an electron injection material of an organic electroluminescence device, and the energy level of HOMO and LUMO can be easily adjusted according to the asymmetric structure.

Pyrazolopyridines and pyrazolopyridazines as antidabetics

The present invention includes compound of formula (I), or a derivative thereof, wherein Y is CH or N; R1 is unsubstituted or substituted alkyl, unsubstituted or substituted cycloalkyl, unsubstituted or substituted alkenyl, unsubstituted or substituted cycloalkenyl, unsubstituted or substituted aryl, aralkyl wherein the aryl and the alkyl moieties may each independently be unsubstituted or substituted, aralkenyl wherein the aryl, and alkenyl moieties may each independently be unsubstituted or substituted, unsubstituted or substituted heterocyclyl, or heterocyclylalkyl wherein the heterocyclyl and the alkyl moieties may each independently be unsubstituted or substituted; and R2 is unsubstituted aryl or unsubstituted or substituted or substituted heteroaryl. Additionally the present invention includes a process for preparing such a compound, a pharmaceutical composition containing such a compound, and the use of such a compound in medicine.